Orthofix Cautiously Optimistic For 2020 Second Half Growth

Orthofix's logo

Orthofix reported orthopedic revenue of USD $73.1 million, -36.9% vs. 2Q19. COVID significantly impacted the company's second-quarter, and while sequential month trends improved, Orthofix exited June down -15%. Sales in July declined -10% versus the prior year. The deformity correction focus of the company's trauma portfolio acted as a...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0